UC96:LSE:LSE-UBS (Irl) ETF plc - Factor MSCI USA Prime Value ESG UCITS ETF (USD) A-dis GBP (GBX)

ETF | Others |

Last Closing

USD 2828

Change

0.00 (0.00)%

Market Cap

USD 0.16B

Volume

6.39K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 636.56B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

N/A

USD 260.39B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing UC96:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.39% 35% F 41% F
Dividend Return 0.01% 19% F 15% F
Total Return 0.40% 34% F 40% F
Trailing 12 Months  
Capital Gain 5.31% 43% F 50% F
Dividend Return 0.01% 9% A- 7% C-
Total Return 5.32% 38% F 47% F
Trailing 5 Years  
Capital Gain 71.03% 75% C 79% B-
Dividend Return 0.10% 11% F 21% F
Total Return 71.13% 72% C 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 12.60% 69% C- 72% C
Dividend Return 12.60% 68% D+ 71% C-
Total Return 0.01% 21% F 13% F
Risk Return Profile  
Volatility (Standard Deviation) 9.63% 70% C- 83% B
Risk Adjusted Return 130.83% 98% N/A 99% N/A
Market Capitalization 0.16B 56% F 32% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.